Senescent Thyroid Tumor Cells Promote Their Migration by Inducing the Polarization of M2-like Macrophages

Overview

Journal Clin Transl Oncol

Specialty Oncology

Date 2021 Jan 3

PMID 33389662

Citations 6

Authors

C Zhang

X Gu

M Pan

Q Yuan

H Cheng

Affiliations

Soon will be listed here.

Abstract

Purpose: An in-depth understanding of the mechanism of thyroid cancer progression will help identify patients with thyroid cancer with a high risk of recurrence and metastasis. Although studies have pointed out that the senescence of thyroid tumor cells may stimulate TAMs and cause a series of changes. However, the role of TAMs in aging thyroid cancer cells is still unknown. The aim of this study was to investigate the function of TAMs in aging thyroid cancer cells.

Methods: We conducted in vitro model studies based on the K1 cell line to induce tumor cell senescence and study its effect on the differentiation of macrophages, flow cytometry was used to confirm polarization of macrophages, transwell assay was used to confirm changes of invasion and migration of tumor cells.

Result: Our data indicate that aging thyroid tumor cell lines trigger the polarization of M2-like macrophages, accompanied by increased expression of CCL17, CCL18, IL-18, and TGFβ1. This event is caused by the activation of the NFκB pathway upregulation of CXCL2 and CXCL3 is related. Further studies have shown that differentiated M2-like macrophages promote tumor cell migration (but have no effect on cell proliferation).

Conclusion: Our study indicating that the interaction between tumor and TAMs also occurs in the advanced stages of thyroid tumors and will lead to faster tumors progress.

Citing Articles

Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.

Xiong J, Dong L, Lv Q, Yin Y, Zhao J, Ke Y Clin Transl Med. 2024; 14(9):e1772.

PMID: 39270064 PMC: 11398298. DOI: 10.1002/ctm2.1772.

IRX5's influence on macrophage polarization and outcome in papillary thyroid cancer.

Qin L, Chen C, Gui Z, Jiang Y Front Oncol. 2024; 14:1399484.

PMID: 38868535 PMC: 11167072. DOI: 10.3389/fonc.2024.1399484.

Tumor-associated macrophages as a potential therapeutic target in thyroid cancers.

Zhu L, Li X, Gangadaran P, Jing X, Ahn B Cancer Immunol Immunother. 2023; 72(12):3895-3917.

PMID: 37796300 PMC: 10992981. DOI: 10.1007/s00262-023-03549-6.

Efficacy of Modified Nonpneumatic Transaxillary Approach in the Treatment of Thyroid Cancer and Its Effect on Immune Function and Parathyroid Function.

Huang T, Sang Y, Zhang J Emerg Med Int. 2022; 2022:3336880.

PMID: 36285179 PMC: 9588369. DOI: 10.1155/2022/3336880.

Roles and new Insights of Macrophages in the Tumor Microenvironment of Thyroid Cancer.

Liu Q, Sun W, Zhang H Front Pharmacol. 2022; 13:875384.

PMID: 35479325 PMC: 9035491. DOI: 10.3389/fphar.2022.875384.

References

Cabanillas M, Ryder M, Jimenez C . Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond. Endocr Rev. 2019; 40(6):1573-1604. PMC: 7341904. DOI: 10.1210/er.2019-00007. View

Grani G, Ramundo V, Verrienti A, Sponziello M, Durante C . Thyroid hormone therapy in differentiated thyroid cancer. Endocrine. 2019; 66(1):43-50. DOI: 10.1007/s12020-019-02051-3. View

Huang J, Harris E, Lorch J . Treatment of Aggressive Thyroid Cancer. Surg Pathol Clin. 2019; 12(4):943-950. DOI: 10.1016/j.path.2019.08.004. View

Chatsirisupachai K, Palmer D, Ferreira S, de Magalhaes J . A human tissue-specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence. Aging Cell. 2019; 18(6):e13041. PMC: 6826163. DOI: 10.1111/acel.13041. View

Bertol B, de Araujo J, Sadissou I, Sonon P, Dias F, Bortolin R . Plasma levels of soluble HLA-G and cytokines in papillary thyroid carcinoma before and after thyroidectomy. Int J Clin Pract. 2020; 74(10):e13585. DOI: 10.1111/ijcp.13585. View

Huang M, Zhang J, Yan C, Li X, Zhang J, Ling R . Small molecule HDAC inhibitors: Promising agents for breast cancer treatment. Bioorg Chem. 2019; 91:103184. DOI: 10.1016/j.bioorg.2019.103184. View

Wu Q, Li B, Sun S, Sun S . Unraveling Adipocytes and Cancer Links: Is There a Role for Senescence?. Front Cell Dev Biol. 2020; 8:282. PMC: 7198697. DOI: 10.3389/fcell.2020.00282. View

Zhang Z, Xu T, Qin W, Huang B, Chen W, Li S . Upregulated PTPN2 induced by inflammatory response or oxidative stress stimulates the progression of thyroid cancer. Biochem Biophys Res Commun. 2019; 522(1):21-25. DOI: 10.1016/j.bbrc.2019.11.047. View

Htwe T, Karim N, Wong J, Jahanfar S, Mansur M . Differential expression of galectin-3 in advancing thyroid cancer cells: a clue toward understanding tumour progression and metastasis. Singapore Med J. 2010; 51(11):856-9. View

10.

Di Mitri D, Mirenda M, Vasilevska J, Calcinotto A, Delaleu N, Revandkar A . Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer. Cell Rep. 2019; 28(8):2156-2168.e5. PMC: 6715643. DOI: 10.1016/j.celrep.2019.07.068. View

11.

Wei C, Yang C, Wang S, Shi D, Zhang C, Lin X . Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Mol Cancer. 2019; 18(1):64. PMC: 6441214. DOI: 10.1186/s12943-019-0976-4. View

12.

Gunda V, Gigliotti B, Ndishabandi D, Ashry T, McCarthy M, Zhou Z . Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer. Br J Cancer. 2018; 119(10):1223-1232. PMC: 6251038. DOI: 10.1038/s41416-018-0296-2. View

13.

Gulubova M, Ivanova K . The Expression of Tumor-Associated Macrophages and Multinucleated Giant Cells in Papillary Thyroid Carcinoma. Open Access Maced J Med Sci. 2020; 7(23):3944-3949. PMC: 7061364. DOI: 10.3889/oamjms.2019.715. View

14.

Troiano G, Caponio V, Adipietro I, Tepedino M, Santoro R, Laino L . Prognostic significance of CD68 and CD163 tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Oral Oncol. 2019; 93:66-75. DOI: 10.1016/j.oraloncology.2019.04.019. View

15.

Choi J, Gyamfi J, Jang H, Koo J . The role of tumor-associated macrophage in breast cancer biology. Histol Histopathol. 2017; 33(2):133-145. DOI: 10.14670/HH-11-916. View

16.

Liu L, Wang X, Li X, Wu X, Tang M, Wang X . Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells. Oncol Rep. 2017; 39(2):818-826. DOI: 10.3892/or.2017.6148. View

17.

Li W, Zhang X, Wu F, Zhou Y, Bao Z, Li H . Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer. Cell Death Dis. 2019; 10(12):918. PMC: 6892854. DOI: 10.1038/s41419-019-2131-y. View

18.

Ryder M, Gild M, Hohl T, Pamer E, Knauf J, Ghossein R . Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression. PLoS One. 2013; 8(1):e54302. PMC: 3553126. DOI: 10.1371/journal.pone.0054302. View

19.

Purcell M, Kruger A, Tainsky M . Gene expression profiling of replicative and induced senescence. Cell Cycle. 2014; 13(24):3927-37. PMC: 4615143. DOI: 10.4161/15384101.2014.973327. View

20.

Wei Z, Guo H, Qin J, Lu S, Liu Q, Zhang X . Pan-senescence transcriptome analysis identified RRAD as a marker and negative regulator of cellular senescence. Free Radic Biol Med. 2018; 130:267-277. DOI: 10.1016/j.freeradbiomed.2018.10.457. View